Aprea Therapeutics Inc.
APRE | NASDAQ
$0.74
-$0.02 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.80
+$0.06 (+8.11%)
After-hours:
Sep 21, 2026, 7:50 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 118.11K | 162.46K | 205.82K | 354.62K | 561.57K | 380.57K | 14.08K | 319.47K | 249.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 5.43K | n/a | n/a | 1.91M | 2.48M | 2.36M | 2.85M | 2.56M | 1.6M | 2.05M | 2.12M | 2.2M | 1.26M | 531.41K | 1.12M | 6.81M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -5.43K | n/a | n/a | -1.79M | -2.32M | -2.15M | -2.49M | -2M | -1.22M | -2.03M | -1.8M | -1.95M | -1.26M | -531.41K | -1.12M | -6.81M | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.03M | -3.43M | -2.64M | -3.12M | -3.39M | -4.09M | -3.23M | -4.1M | -3.85M | -3.15M | -3.67M | -3.52M | -3.65M | -4.62M | -2.65M | -4.2M | -98.47M | -8.07M | -7.83M | -9.43M | -10M | -10.19M |
Interest Income | 358.92K | 134.78K | 118.66K | 150.67K | 178.03K | 204.73K | 274.63K | 348.74K | 382.37K | 283.4K | 310.29K | 321.22K | 336.22K | 256.41K | 243.08K | 151.12K | 52.49K | 1.97K | 3.33K | n/a | n/a | 0 |
Pretax Income | -3.59M | -3.29M | -2.46M | -2.97M | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -98.26M | -7.94M | -7.76M | -9.45M | -10.25M | -9.67M |
Net Income | -3.59M | -3.29M | -2.46M | -2.97M | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -98.26M | -7.94M | -7.76M | -9.45M | -10.25M | -9.67M |
Selling & General & Admin | 1.57M | 1.81M | 1.64M | 1.48M | 1.59M | 1.76M | 1.07M | 1.61M | 1.85M | 1.93M | 1.64M | 1.72M | 1.7M | 3.37M | 2.12M | 3.08M | 15.63M | 3.99M | 3.37M | 3.41M | 3.34M | 3.43M |
Research & Development | 2.46M | 1.61M | 1.01M | 1.64M | 1.91M | 2.48M | 2.36M | 2.85M | 2.56M | 1.6M | 2.05M | 2.12M | 2.2M | 1.26M | 531.41K | 1.12M | 82.83M | 4.09M | 4.46M | 6.02M | 6.65M | 6.76M |
Other Expenses | n/a | n/a | -3.34K | -1.85K | -1.91M | -2.48M | -2.36M | -2.85M | -2.56M | -1.6M | -2.05M | -2.12M | -2.2M | -1.26M | -531.41K | -1.12M | -6.81M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.03M | 3.42M | 2.64M | 3.12M | 1.59M | 1.76M | 1.07M | 1.61M | 1.85M | 1.93M | 1.64M | 1.72M | 1.7M | 3.37M | 2.12M | 3.08M | 91.65M | 8.07M | 7.83M | 9.43M | 10M | 10.19M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33 | 588 | 1.06K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.03M | 3.43M | 2.64M | 3.12M | 3.51M | 4.25M | 3.43M | 4.45M | 4.41M | 3.53M | 3.69M | 3.84M | 3.9M | 4.62M | 2.65M | 4.2M | 98.47M | 8.07M | 7.83M | 9.43M | 10M | 10.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 53.48M | 7.69M | 7.69M | 6.37M | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.73M | 3.73M | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
Shares Outstanding (Diluted) | 53.48M | 7.69M | 7.69M | 6.37M | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.73M | 3.73M | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
EPS (Basic) | -0.07 | -0.43 | -0.32 | -0.47 | -0.53 | -0.66 | -0.49 | -0.64 | -0.58 | -0.67 | -0.92 | -0.86 | -0.87 | -1.27 | -834.43 | -2.41 | -86.76 | -7.25 | -7.20 | -8.90 | -9.68 | -9.13 |
EPS (Diluted) | -0.07 | -0.43 | -0.32 | -0.47 | -0.53 | -0.66 | -0.49 | -0.64 | -0.58 | -0.67 | -0.92 | -0.86 | -0.87 | -1.27 | -834.43 | -2.41 | -86.76 | -7.25 | -7.20 | -8.90 | -9.68 | -9.13 |
EBITDA | -3.59M | -3.28M | -2.45M | -2.97M | -3.23M | -3.93M | -2.89M | -3.78M | -3.46M | -2.8M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -22.44M | -7.87M | -7.69M | -9.38M | -10.19M | -10.11M |
EBIT | -3.59M | -3.29M | -2.46M | -2.97M | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -22.45M | -7.94M | -7.76M | -9.45M | -10.25M | -10.19M |
Depreciation & Amortization | 5.75K | 5.43K | 5.43K | 5.43K | 5.43K | 5.43K | 5.43K | 5.43K | 5.3K | 6.16K | 4.99K | 1.43K | 224 | 410 | 1.1K | 122 | 3.72K | 63.77K | 65.99K | 69.44K | 60.24K | 76K |
Add to Watchlist
Select watchlists to add or remove APRE